Zarnestra
Term · Oncology and biomedicine · MLC-T-ONC-009460
A substance that is being studied in the treatment of acute myeloid leukemia (AML) and other types of cancer. It belongs to the family of drugs called farnesyltransferase inhibitors. Also called R115777 and tipifarnib.
| Identifier | MLC-T-ONC-009460 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | R115777; tipifarnib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009460",
"term": "Zarnestra",
"field": "Oncology and biomedicine",
"definition": "A substance that is being studied in the treatment of acute myeloid leukemia (AML) and other types of cancer. It belongs to the family of drugs called farnesyltransferase inhibitors. Also called R115777 and tipifarnib.",
"synonyms": [
"R115777",
"tipifarnib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/zarnestra/"
}
Record 17,601 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.